Q&A

Early intervention has become a central component of retinal care in South Korea, a shift that has significantly enhanced therapeutic outcomes. Physicians encourage regular screenings for individuals with chronic diseases such as diabetes, as early signs of retinal changes often go unnoticed without specialized imaging. Early detection enables the timely administration of retinal drugs that can slow or halt disease progression. Korean healthcare systems streamline diagnostic-to-treatment timelines, minimizing delays that often worsen retinal damage. This proactive approach has increased demand for drugs targeting early-stage degeneration and microvascular abnormalities.

At the same time, South Korea is improving management strategies for chronic retinal conditions. Patients receive personalized therapy schedules, long-term monitoring, and educational resources to ensure consistent follow-up. Clinicians employ digital tools and AI-based imaging software to track treatment response and adjust drug doses accordingly. These efforts foster stronger patient engagement and adherence, which are critical for managing lifelong conditions such as diabetic retinopathy and age-related macular degeneration. South Korea’s commitment to early intervention underscores its role as a leader in proactive retinal healthcare.